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CD4 and CD8 lineage T cells develop in the thymus through 
a series of complex selection events evolved to identify those 
thymocytes with self-MHC–restricted TCRs and direct 
their development to the appropriate subset. There has been 
considerable interest in defining the signaling pathways and 
transcriptional networks responsible for controlling T cell 
development. NF-κB transcription factors regulate the sur-
vival, function, and development of many cell types, includ-
ing those of the immune system (Bonizzi and Karin, 2004). 
Canonical NF-κB signaling is mediated by the inhibitor of 
κ B kinase (IKK) complex, comprised of two catalytic sub-
units, IKK1 (IKKα) and IKK2 (IKKβ), and a regulatory ubiq-
uitin-binding adaptor, NEMO (IKKγ). Phosphorylation by 
the IKK complex targets inhibitor of κ Bα (IκBα) for degra-
dation by the proteasome, releasing associated NF-κB1 p50/
Rel and NF-κB1 p50/cRel dimers to enter the nucleus and 
stimulate gene transcription.
NF-κB has been shown to control T cell development 
at various checkpoints. Inhibition of NF-κB activity by T cell 
expression of a degradation-resistant IκBα super-repressor 
blocks the CD4 CD8 double-negative (DN) to CD4 CD8 
double-positive (DP) transition, suggesting a role for NF-κB 
downstream of the pre-TCR complex in DN thymocytes 
(Voll et al., 2000). Super-repressor IκBα expression has also 
be reported to inhibit positive selection of CD8 SP thy-
mocytes, which have the highest level of detectable NF-κB 
activity in the thymus (Mora et al., 1999; Hettmann and 
Leiden, 2000). Consistent with this, transgenic expression of 
a constitutively active IKK2 mutant to increase NF-κB in 
T cells enhances CD8 SP development (Jimi et al., 2008). 
Because TCR signals regulate TCRβ selection in DN thy-
mocytes, and positive and negative selection at the DP stages, 
it is thought that the observed functions of NF-κB are the 
result of TCR-dependent triggering. However, TCR activa-
tion of the IKK complex in peripheral T cells is mediated 
via a complex comprising Card11, Bcl10, and Malt1 proteins 
(the CBM complex) that is not required for thymocyte de-
velopment (Schmidt-Supprian et al., 2004). This implies that 
the TCR in thymocytes stimulates IKK independently of the 
CBM complex or that another receptor is responsible for ac-
tivating NF-κB in these cells.
In the present study, we reinvestigated the role of NF-κB 
in thymocyte development using mice in which both Ikk1 
and Ikk2 genes had been deleted in early thymic progenitors 
(IKKΔT). Thymic development was completely arrested at 
the HSAhi SP stage. In vitro experiments demonstrated that 
blockade of NF-κB activation specifically sensitized thymo-
cytes to TNF-induced cell death. In line with this, inhibiting 
TNF signaling with an antibody or deletion of TNF RI res-
cued the development of SP thymocytes in IKKΔT mice. 
These results reveal a critical role for TNF in the develop-
ment of SP T cells in the thymus.
NF-κB activation has been implicated at multiple stages of thymic development of T cells, during which it is thought to me-
diate developmental signals originating from the T cell receptor (TCR). However, the Card11–Bcl10–Malt1 (CBM) complex that 
is essential for TCR activation of NF-κB in peripheral T cells is not required for thymocyte development. It has remained un-
clear whether the TCR activates NF-κB independent of the CBM complex in thymocyte development or whether another 
NF-κB activating receptor is involved. In the present study, we generated mice in which T cells lacked expression of both 
catalytic subunits of the inhibitor of κB kinase (IKK) complex, IKK1 and IKK2, to investigate this question. Although early 
stages of T cell development were unperturbed, maturation of CD4 and CD8 single-positive (SP) thymocytes was blocked in 
mice lacking IKK1/2 in the T cell lineage. We found that IKK1/2-deficient thymocytes were specifically sensitized to TNF-in-
duced cell death in vitro. Furthermore, the block in thymocyte development in IKK1/2-deficient mice could be rescued by 
blocking TNF with anti-TNF mAb or by ablation of TNF RI expression. These experiments reveal an essential role for TNF acti-
vation of NF-κB to promote the survival and development of single positive T cells in the thymus.
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RES ULTS AND DIS CUS SION
NF-κB signaling is redundant for development  
and selection of DP thymocytes, but essential  
for SP thymocyte maturation
To investigate the role of NF-κB signaling in thymocyte 
development, we used the Cre-Lox system to delete condi-
tional alleles of Ikk1 and Ikk2 genes within the T cell lineage. 
Previous studies show that thymic development proceeds 
relatively normally in the absence of either Ikk1 or Ikk2 ex-
pression (Schmidt-Supprian et al., 2003; Chen et al., 2015), 
even when gene deletion occurs early in T cell development 
in DN2 thymocytes (Silva et al., 2014), with the exception 
of thymic regulatory T cell development that is reduced by 
lack of either IKK1 or IKK2. This suggests that there is sig-
nificant redundancy between these two subunits for activat-
ing IKK activity and canonical NF-κB signaling. Therefore, 
to achieve a complete block in IKK function, we generated 
Ikk1fx/fx Ikk2fx/fx mice to delete both kinase subunits, using 
either huCD2iCre to delete in DN2 thymocytes (IKKΔTCD2) 
or CD4Cre to delete in DP thymocytes (IKKΔTCD4). Cre ac-
tivity was monitored by the inclusion of Rosa26RYFP reporter 
alleles (Srinivas et al., 2001). Surprisingly, early deletion of 
IKK genes by huCD2iCre did not result in any obvious defects 
in DN or DP development. Number and representation of 
DN3 and DN4 thymocytes were not obviously perturbed in 
IKKΔTCD2 mice (Fig. 1 A). Similarly, subsets of DP thymo-
cytes defined by expression of TCR and CD5 (Saini et al., 
2010) were normally represented (Fig. 1 B). In contrast, the 
TCRhi SP compartment was profoundly affected. Percent-
ages of both CD4SP and CD8SP were reduced (Fig. 1 C) 
and analysis of cell phenotype revealed that mature HSAlo 
SPs were greatly reduced in number in the absence of 
Ikk genes (Fig. 1 C). This block in development was also ev-
ident in IKKΔTCD4 mice in which gene deletion occurred at 
the DP stage (Fig. 1 D). In the periphery, there was a corre-
sponding reduction in the naive T cell compartment in IK-
KΔTCD2 mice compared with controls (Fig.  1 E). The few 
naive, memory, and regulatory cells present (Fig. 1 E) were 
largely Cre reporter YFP-negative (Fig.  1  F) and therefore 
most likely represent escapants, in which Ikk1 and/or Ikk2 
gene deletion was incomplete. Together, these data demon-
strate a critical role for IKK1/2 in the development of SP thy-
mocytes, whereas earlier stages of thymocyte development are 
IKK1/2-independent. These results are consistent with earlier 
reports on the effects of Nemo deficiency upon development 
of SP thymocytes (Schmidt-Supprian et al., 2003).
IKK1/2-deficient thymocytes are specifically sensitive 
to TNF-induced apoptosis
We next investigated which receptors might be responsible for 
triggering the NF-κB activation required for SP thymocyte 
development, other than TCR. TNF receptor superfamily 
(Tnfrsf) members are potent activators of NF-κB, and those 
receptors with death domains can also recruit the adapter 
TRA DD and/or FADD to trigger caspase-induced cellular 
Figure 1. Deletion of Ikk1 and Ikk2 blocks SP thymocyte devel-
opment. Lymphoid organs from 8–12-wk-old Ikk1fx/fx Ikk2fx/fx R26REY FP 
huCD2iCre (IKKΔTCD2, n = 16) were analyzed by FACS and compared with 
huCD2iCre -ve (Cre−, n = 15) littermate as control. (A) Density plots are of 
CD44 versus CD25 by DN Lin− (CD4, CD8, TCRαβ, and CD5) thymocytes. 
Numbers indicate percentage in the corresponding quadrant. Bar charts 
are cell number of CD44hiCD25hi (DN2), CD44loCD25hi (DN3), and CD44lo 
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apoptosis or necroptosis (Vandenabeele et al., 2010). One 
possible role for NF-κB in developing thymocytes could be 
to prevent induction of cell death induced by such receptors.
Our previous studies reveal that SP thymocytes express 
Tnfrsf members TNF receptor I and II, CD27 (Tnfrsf7), 
TACI (Tnfrsf13b), LIG HTR (Tnfrsf14), GITR (Tnfrsf18), 
Tnfrsf25, and Tnfrsf26 (Silva et al., 2014). We therefore asked 
whether ligands for these receptors could induce apopto-
sis in IKK1/2-deficient thymocytes, which could account 
for the phenotype of IKKΔT mice. Thymocytes from 
IKKΔTCD4 mice were cultured overnight with TNF (ligand 
for TnfrI and TnfrII), CD27L, APR IL, or BAFF (TACI li-
gands), LIG HT (LIG HTR ligand), TRA IL (ligand for 
Tnfrsf26), GIT RL (GITR ligand), or TL1A (ligand for DR3/
Tnfrsf25), and then viability assessed. Thymocyte survival 
was unaffected by all ligands except TNF which induced a 
substantial increase in cell death in SP thymocytes (Fig. 2 A). 
To examine this in more detail, we measured TNF-induced 
cell death on different thymic subsets from IKKΔTCD4 mice, 
as well as WT and Tnfrsf1a−/− donors as controls. TNF pro-
moted cell death in a small fraction of DP and HSAhi CD4SP 
subsets from both WT and IKKΔTCD4 donors. In contrast, 
TNF stimulation had no effect upon cell viability of HSAlo 
CD4SP or either CD8SP subset from WT mice, but induced 
high levels of cell death in the same populations from IK-
KΔTCD4 mice (Fig. 2 B). The viability of thymocytes from 
Tnfrsf1a−/− mice was unaffected by TNF, confirming that 
TNF RI was required to transmit proapoptotic TNF signals 
in DP and HSAhi CD4 SP.
The few SP cells that developed in IKKΔTCD4 mice 
were highly sensitive to TNF-induced cell death in vitro, 
consistent with earlier studies that IKK2-deficient T cells 
are sensitive to TNF-induced cell death (Senftleben et al., 
2001). However, development of IKK2-deficient thymo-
cytes is normal (Schmidt-Supprian et al., 2003; Silva et al., 
2014), in contrast to that of IKKΔT mice. Because IKKΔT 
cells had developed in the absence of IKK1/2, it was un-
clear whether the sensitivity of SP cells to TNF reflected 
a normal requirement for IKK1/2 for their survival after 
TNF stimulation. To investigate this, we analyzed responses 
of thymocytes from huCD2iCre Ikk1fx/fx mice cultured with 
IKK2-specific inhibitor Bl605906 (Clark et al., 2011). In the 
absence of IKK1 protein, IKK2 inhibition results in a near 
complete block in canonical NF-κB signaling (Clark et al., 
2011). Importantly, thymic development in IKK1-deficient 
mice is grossly normal (Chen et al., 2015). Thymocytes from 
huCD2iCre Ikk1fx/fx mice (lacking only IKK1) were resis-
tant to TNF-induced cell death, similar to WT thymocytes. 
Only a small fraction of HSAhi CD4SP were induced to die 
by TNF, whereas viability of all other SP subsets were un-
affected by TNF (Fig.  2  C). However, culture with IKK2 
inhibitor rendered HSAlo CD4SP and both subsets of CD-
8SPs from huCD2iCre Ikk1fx/fx mice profoundly susceptible 
to death induction by TNF (Fig.  2 C). TNF also induced 
active caspase 8 in cultures of huCD2iCre Ikk1fx/fx thymocytes 
and IKK2 inhibitor, providing evidence that TNF induced 
apoptotic cell death. Together, these data suggest that TNF 
RI activation of IKK/NF-κB activity was required to pro-
tect thymocytes from TNF-induced apoptosis. The suscepti-
bility of thymic subsets to TNF-induced apoptosis in vitro, 
as assessed by Bl605906 IC50 values (Fig. 2 E), mirrored the 
phenotype of IKK1/2-deficient thymocytes in vivo. HSAhi 
CD4SPs were least susceptible to TNF-induced cell death 
in vitro and were minimally affected in IKKΔTCD4 mice. In 
contrast, HSAlo CD8SP thymocytes were most sensitive to 
TNF-induced cell death in the absence of IKK activity and 
were virtually absent from IKKΔTCD4 mice.
Because the IKK complex is known to regulate cell 
function independently of NF-κB (Yan et al., 2013; Don-
delinger et al., 2015), it was important to confirm that the ef-
fects of IKK1/2 deficiency on thymocyte development were 
actually due to reduced NF-κB activation. First, we con-
firmed that IKK2 blockade in IKK1-deficient thymocytes 
did indeed prevent NF-κB activation by TNF (Fig.  2  F). 
Second, we analyzed a transgenic mouse strain in which thy-
mocytes express a dominant-negative inhibitor of κB (pLck-
IκB-PEST), in which CD8SP development is significantly 
impaired (Mora et al., 1999). HSAlo CD4SP, HSAhi CD8SP, 
and HSAlo CD8SP thymocytes from pLck-IκB-PEST mice 
were more susceptible to TNF-induced cell death, whereas 
HSAhi CD4SP remained relatively unaffected by IκB-PEST 
expression compared with controls (Fig. 2 G). These results 
confirm that TNF activation of NF-κB is required for thy-
mocyte survival in vitro.
CD25lo (DN4) DN thymocyte subsets. (B) Density plots are of TCR versus 
CD5. Numbers indicate percentage in the corresponding gate. Bar charts 
are cell number of CD5loTCRlo (DP1), CD5hiTCRint (DP2), and CD5intTCRhi (DP3) 
DP subsets. (C) Density plots are of CD4 versus CD8 expression by total live 
thymocytes and TCR versus HSA by CD4SP and CD8SP gated thymocytes. 
Bar charts show numbers of the indicated SP subset from IKKΔTCD2 mice 
(Cre+) and huCD2iCre -ve (Cre−) littermates. Numbers indicate fold differ-
ence in counts between Cre− and Cre+. (D) Density plots are of CD4 versus 
CD8 expression by total live thymocytes, TCR versus CD5 by DP thymo-
cytes, and TCR versus HSA by CD4SP and CD8SP gated thymocytes from IK-
KΔTCD4 mice or Cre− littermates. (E) Density plots are CD25 versus CD44 by 
CD4+TCRhi gated lymph node cells and CD44 versus TCR by CD8+TCRhi gated 
lymph node cells from the indicated strains and show gates used to de-
fine naive (CD44lo CD25−), memory (CD44hi CD25−), and T reg (CD25+) cells 
among CD4+TCRhi cells, and naive (CD44lo) and memory (CD44hi) among 
CD8+TCRhi cells. Bar charts show total number of naive, memory, and T 
reg cells recovered from lymph node and spleen of IKKΔTCD2 mice (Cre+) 
and huCD2iCre -ve (Cre−) littermates. Numbers indicate fold difference in 
naive cell counts between Cre− and Cre+ hosts. (F) Histograms are of EYFP 
expression by naive, memory, and regulatory CD4+TCRhi T cells and naive 
and memory CD8+TCRhi T cells from IKKΔTCD2 mice and huCD2iCre Ikk1fx/
WT Ikk2fx/WT R26REY FP littermate controls (WT). Numbers indicate percentage 
of IKKΔTCD2 cells (solid lines) expressing YFP. FACS data are representative 
of four or more experiments and cell number data are pooled from four 
experiments. ****, P < 0.0001.
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Blockade of TNF signaling via TNF RI rescues IKKΔT 
SP thymocyte development
We next asked whether the susceptibility of SP thymocytes 
to TNF-induced cell death observed in vitro could account 
for the abnormal thymic development in mice with impaired 
NF-κB signaling. IKKΔTCD4 mice were treated with neu-
tralizing anti-TNF mAb for 7 d. This short period of TNF 
blockade was sufficient to restore both HSAlo CD4SP and 
total CD8SP thymic subsets in treated mice (Fig. 3 A). Ex-
amining T cells in lymph nodes of treated mice at day 7 re-
vealed a significant increase in the number of naive T cells in 
anti-TNF–treated mice, suggesting that newly developing SP 
cells were also able to emigrate to the periphery (Fig. 3 B). 
To determine if TNF signaling was transmitted by TNF RI 
receptor, we additionally generated Tnfrsf1a−/− IKKΔTCD4 
mice. Loss of TNF RI expression also restored development 
of mature SP subsets in IKKΔTCD4 mice (Fig. 3 C). Enumer-
ating different subsets of thymocytes revealed that anti-TNF 
treatment resulted in comparable rescue of SP thymic de-
velopment in IKKΔTCD4 mice to that in Tnfrsf1a−/− IK-
KΔTCD4 mice (Fig. 3 D).
Analyzing the periphery of Tnfrsf1a−/− IKKΔTCD4 
mice revealed a substantial increase in numbers of naive T 
cells compared with IKKΔTCD4 controls (Fig.  3  E). How-
ever, repopulation was still only a fraction of that observed in 
Cre-WT controls. We have previously shown that NF-κB sig-
naling is required for normal expression of IL-7Rα by naive 
T cells, which is necessary for their long-term survival (Silva 
et al., 2014). Naive T cells from Tnfrsf1a−/− IKKΔTCD4 mice 
displayed a substantial reduction in IL-7Rα levels compared 
with controls (Fig. 3 E). Impaired IL-7Rα expression there-
fore may explain why Tnfrsf1 deletion in absence of IKK1/2 
expression did not rescue naive T cell numbers more effi-
ciently in the periphery.
Lastly, we asked whether the defect in CD8SP develop-
ment reported in pLck IκB-PEST mice could also be cor-
rected by anti-TNF treatment. Analyzing thymocytes from 
pLck-IκB-PEST mice revealed that the reduced abundance of 
CD8SP was a result of a specific reduction in HSAlo CD8SP 
thymocytes (Fig.  4), that we also found to be most sensi-
Figure 2. TNF induces thymocyte cell death in the absence of IKK 
activity in vitro. (A) Thymocytes from Ikk1fx/fx Ikk2fx/fx R26REY FP CD4Cre (IK-
KΔTCD4) mice were cultured overnight with the indicated Tnfrsf member, 
and viability of the indicated SP subset assessed the next day by FACS. (B) 
Thymocytes from IKKΔTCD4, Cre -ve littermates (Cre -ve), and Tnfrsf1a−/− 
donors were cultured overnight with and without TNF (30 ng/ml). Bar chart 
shows viability among the indicated subsets cultured with addition of PBS 
(open bars) or TNF (filled bars) as assessed by FACS. (C) Thymocytes from 
WT and Ikk1fx/fx R26REY FP huCD2iCre donors were cultured overnight in the 
presence of TNF or IKK2 inhibitor Bl605906, or both. Bar chart shows per-
centage of viability among the indicated subsets as assessed by FACS. (D) 
Ikk1fx/fx R26REY FP huCD2iCre thymocytes were cultured for 4 h in the presence 
of TNF and/or IKK2 inhibitor Bl605906. Density plots are of live dead versus 
active caspase 8 stain by CD8 SP thymocytes. (E) Thymocytes from Ikk1fx/fx 
R26REY FP huCD2iCre donors were cultured with IKK2 inhibitor and a titration 
of TNF. Line graph shows the percentage of maximum TNF-induced death 
for different concentrations of TNF, above background, for the indicated 
subsets. Concentrations in figure legend indicate LD50 of TNF for the cor-
responding subset. (F) Thymocytes from WT or Ikk1fx/fx R26REY FP huCD2iCre 
donors were pre-incubated with IKK2 inhibitor Bl605906 or DMSO vehicle 
for 1 h where indicated, and then stimulated with TNF and nuclear extracts 
prepared at different times. Bar charts represent RelA binding to NF-κB 
binding oligonuclotides as detected by ELI SA and displayed as OD. Dot-
ted line indicates the background signal from blank wells. (G) Thymocytes 
from pLck-IκB-PEST donors or transgene -ve littermates were cultured in 
different concentrations of TNF overnight. Line graphs are of percentage 
dead cells in the indicated subsets from pLck-IκB-PEST donors (IκB-PEST, 
filled circles) or transgene negative litter controls (WT, open circles). Error 
bars indicate SD of technical duplicates. Data are representative of two (F), 
three (G), or more (A–E) independent experiments. *, P < 0.05; ***, P < 0.001.
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tive to TNF-induced cell death in vitro (Fig. 2 E). Consistent 
with this, TNF blockade in these mice for 7 d resulted in 
restoration of normal HSAlo CD8SP compartment (Fig. 4), 
suggesting that TNF-induced cell death accounted for the 
apparent skew in T cell development that had previously been 
interpreted as a block in selection of CD8 lineage cells.
An absence of TNF gene targets from 
IKK-deficient SP thymocytes
The mechanisms by which NF-κB activation protects cells 
from TNF-induced cell death have been intensively studied in 
a variety of cell types. Several NF-κB target genes have been 
identified that regulate cell survival after TNF stimulation, in-
cluding cFLIP, Traf1, Traf2, and members of the inhibitors of 
apoptosis (IAP) family (Chu et al., 1997; Wang et al., 1998; 
Kreuz et al., 2001; Micheau et al., 2001; Turner et al., 2007). 
Conversely, NF-κB–induced expression of Cyld has been re-
ported to provide negative feedback to TNFR signaling and 
NF-κB activation (Jono et al., 2004). Transcriptional profiling 
was used to investigate whether any of these NF-κB targets 
might regulate TNF-induced thymocyte survival. TCR trans-
genic CD8SP thymocytes were stimulated with TNF in vitro 
for 4  h and gene expression was determined by RNAseq. 
Analysis of gene expression revealed the induction of several 
classical NF-κB targets, such as NF-κB1, NF-κB2, inhibitor 
of κBa (Nfkbia), and Bcl3 (Haskill et al., 1991; Ten et al., 1992; 
Lombardi et al., 1995; Brocke-Heidrich et al., 2006), as well as 
other reported targets Traf1 and Il7r (Schwenzer et al., 1999; 
Miller et al., 2014; Fig.  5  A). The prosurvival genes, Cflar 
(cFLIP) and Xiap were not induced by TNF stimulation of 
thymocytes. Levels of Cyld and Diablo/SMAC mRNAs were 
unaffected by TNF stimulation. In contrast, the expression of 
Figure 3. TNF blockade rescues SP development in IKKΔTCD4 mice. (A 
and B) Ikk1fx/fx Ikk2fx/fx R26REY FP CD4Cre (IKKΔTCD4) mice (8–16 wk old) were 
treated with anti-TNF mAb i.p. (1 mg/inject; n = 16) or PBS as control (n = 
17). After 7 d, thymus and lymph node cells were analyzed by FACS. (A) 
Density plots are of TCR versus HSA expression by CD4SP (top row) and 
CD8 SP (bottom row) from IKKΔTCD4 mice treated with anti-TNF or PBS 
as compared with untreated Cre -ve littermate controls (Cre–, n = 17). Bar 
charts show total cell recoveries of HSAhi and HSAlo cells among CD4SP 
(top row) and CD8SP (bottom row). (B) Density plots are of CD44 versus 
CD25 by CD4+TCRhi T cells (top row) and CD44 versus TCR by CD8+ cells 
from lymph nodes of the same treatment groups described in A. Bar charts 
show cell numbers of naive CD4 (top chart) and naive CD8 (bottom chart) 
T cells from mice. (C) Density plots are of CD4 versus CD8 by total live 
thymocytes (top row), and TCR versus HSA by CD4SP (middle row) and 
CD8SP thymocytes (bottom row) from IKKΔTCD4 mice, Cre -ve littermate 
controls (Cre–), Tnfrsf1a−/− IKKΔTCD4 mice (n = 16), and Cre -ve littermate 
controls (Tnfrsf1a−/− Cre–, n = 13). (D) Bar charts show cell numbers of the 
indicated SP subset recovered from IKKΔTCD4 mice treated with anti-TNF 
(αTNF) or PBS as described in A, untreated Cre -ve littermates (Cre–), or 
Tnfrsf1a−/− IKKΔTCD4 mice and Cre -ve littermate controls (Tnfrsf1a−/− Cre–). 
(E) Bar charts show total numbers of naive CD44lo CD25– CD4+ TCRhi T cells 
and naive CD44lo CD8+ TCRhi T cells from lymph nodes of Ikk1fx/fx Ikk2fx/fx 
R26REY FP CD4Cre (IKKΔTCD4, n = 17) mice, Cre -ve littermates (Cre–, n = 17), 
Tnfrsf1a−/− IKKΔTCD4 mice (n = 16), and Cre -ve littermate (Cre– Tnfrsf1a−/−, 
n = 13) as control. Histograms are of IL-7Rα by gated naive CD44lo CD25– 
CD4+ TCRhi T cells (top) and naive CD44lo CD8+ TCRhi T cells (bottom) from 
WT (black broken lines), Tnfrsf1a−/− IKKΔTCD4 mice (red solid lines) and Cre 
-ve Tnfrsf1a−/− littermates (solid line). Gray fills are IL-7Rα expression by 
DP thymocytes from WT mice as negative control. FACS data are represen-
tative of four or more independent experiments, and bar charts are pooled 
from four or more independent experiments. ****, P < 0.0001.
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Figure 5. cIAP1 and cIAP2 expression is induced by TNF in vitro and is NF-κB dependent in vivo. (A) TCRhi CD8SP thymocytes from F5 Rag1−/− 
donors were sort purified and stimulated with TNF (n = 4) or PBS (n = 4) as control. mRNA was isolated from cultured and uncultured cells (0 h, n = 3) and 
gene expression determined by RNAseq analysis. Bar charts show mRNA expression level (normalized reads per kb exons per million reads, nRPKM) of the 
indicated genes. Names in brackets indicate protein name associated with gene. (B) TCRhi CD8SP thymocytes were sorted from WT (n = 3) and Tnfrsf1a−/− 
IKKΔTCD4 mice (n = 4). mRNA was purified and gene expression was determined by RNAseq analysis. Bar charts show mRNA expression level (nRPKM) of the 
indicated genes. Individual RNAseq libraries were generated from independent cell preparation and treatments. *, P < 0.05.
Figure 4. TNF blockade rescues the developmental block in 
pLck IκB-PEST mice. pLck IκB-PEST mice were treated with an-
ti-TNF (n = 8; 1 mg, days 0, 2, and 4) or PBS (n = 8) injection as 
control. At day 7, thymi were analyzed by FACS. Density plots are 
of CD4 versus CD8 by total live (top row) and HSA versus TCR by 
CD8SP gated thymocytes from pLck IκB-PEST mice treated with 
either anti-TNF (αTNF) or PBS as control. Transgene -ve (WT, n = 
4) littermates were also analyzed as control. Bar charts show total 
cell numbers of the indicated thymocyte subset recovered from 
the indicated treatment groups. Data are pooled from two inde-
pendent experiments. **, P < 0.01.
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Birc3 (cIAP2) mRNA was strongly increased by TNF stimu-
lation, and Birc3 (cIAP2) mRNA to a lesser extent.
To test whether expression of any of these NF-κB tar-
get genes was reduced in IKK1/2-deficient thymocytes, we 
performed RNAseq on sorted CD8SP thymocytes from Tn-
frsf1a−/− IKKΔTCD4 and control WT mice. Although TNF RII 
gene expression (Tnfrsf1b) was modestly induced by TNF in 
vitro, no modulation was observed in IKKΔTCD4 mice in vivo 
(Fig. 5), arguing against a role for modulated TNF RII levels 
in the rescue of development by TNF blockade. Significantly, 
those genes found to be positively regulated by TNF in vitro 
were all expressed at reduced levels in vivo in the absence of 
IKK1/2 (Fig. 5 B). Similarly, those potential NF-κB targets 
that were not regulated in vitro were also unaffected by IKK 
ablation in vivo (Fig. 5 B). Together, these data suggest that 
defective IAP2 and IAP1 expression sensitizes IKK1/2-defi-
cient thymocytes to TNF-induced cell death.
Conclusion
The role of NF-κB signaling during development of conven-
tional T cells has previously been almost exclusively consid-
ered in the context of TCR signaling. Our study identifies 
TNF as the key trigger of NF-κB activation required to pro-
mote thymocyte development. CD8 SP thymocytes were es-
pecially sensitive to TNF-induced cell death in the absence 
of NF-κB activation, and this likely accounts for the apparent 
selective defects in CD8 lineage development previously re-
ported and attributed to altered TCR selection signaling.
We recently showed that Il7r is a NF-κB target gene 
necessary for long-term survival of peripheral naive T cells 
(Silva et al., 2014), and it seems likely that NF-κB regulates 
other gene targets necessary for normal T cell function. Our 
study also aligns development of conventional T cells with 
that of regulatory T cells, which rely upon the cooperative 
activity of several Tnfrsf members for their development 
(Mahmud et al., 2014). Determining whether TNFR co-
operates with other Tnfrsf members and the role of NF-κB 
activation downstream of such receptors will be important 
areas for future studies.
MAT ERI ALS AND MET HODS
Mice. Mice with conditional alleles of Ikk2 (Ikk2fx/fx; Li et 
al., 2003) and Ikk1 (Ikk1fx/fx; Gareus et al., 2007) were inter-
crossed with mice either expressing transgenic Cre under the 
control of the human CD2 (huCD2; de Boer et al., 2003) 
or CD4 expression elements. Rosa26 reporter YFP allele 
(R26REY FP; Srinivas et al., 2001) was also used to facilitate 
identification of cells in which Cre recombinase had been ac-
tive, and CD4Cre strains were additionally backcrossed onto 
a Tnfrsf1a−/− background. Ikk1fx/fx Ikk2fx/fx R26REY FP huC-
D2iCre (IKKΔTCD2), Ikk1fx/fx R26REY FP huCD2iCre, Ikk1fx/fx 
Ikk2fx/fx R26REY FP CD4Cre (IKKΔTCD4), and Tnfrsf1a−/− Ik-
k1fx/fx Ikk2fx/fx R26REY FP CD4Cre (Tnfrsf1a−/− IKKΔTCD4), 
together with F5 Rag1−/− and pLck IκB-PEST (Voll et al., 
2000) mice, were bred in a conventional colony free of patho-
gens at the National Institute for Medical Research (Lon-
don, England, UK). All mice are on a C57Bl6/J background 
(N5) except F5 Rag1−/− strains that are on a mixed H-2b 
C57BL6/J/129S1/SvlmJ background. Groups of mice were 
treated with anti-TNF mAb (Clone XT3.11; Bio X Cell), 
with a 1-mg/injection delivered i.p. Controls received injec-
tions of PBS. Animal experiments were performed according 
to institutional guidelines and Home Office regulations.
Flow cytometry. Flow cytometric analysis was performed 
with 2–5 × 106 thymocytes and 1–5 × 106 lymph node or 
spleen cells. Cell concentrations of thymocytes, lymph node, 
and spleen cells were determined with a Scharf Instruments 
Casy Counter. Cells were incubated with saturating concen-
trations of antibodies in 100 µl of PBS containing BSA (0.1%) 
and 1 mM azide (PBS-BSA-azide) for 45 min at 4°C, fol-
lowed by two washes in PBS-BSA-azide. Phycoerythrin 
(PE)–conjugated antibody against IL-7Rα, EF450-conju-
gated antibodies against CD4, APC-conjugated antibody 
against CD5, PE-Cy5– and PerCPcy5.5-conjugated antibody 
against TCR (H57-597), APC-Cy7– and APC-conjugated 
antibody against CD44, pacific orange (PO)–conjugated an-
tibody against CD8, PE-Cy7–conjugated antibody against 
CD25, and PE-Cy7–conjugated antibody against HSA/
CD24 were purchased from eBioscience. Cell viability was 
determined using LIVE/DEAD cell stain kit (Invitrogen) and 
active Caspase 8 was detected using CaspGLOW Red Active 
Caspase-8 Staining kit (BioVision Inc.), following the manu-
facturer’s protocol. Eight-color flow cytometric staining was 
analyzed on a FAC SCanto II or LSRFortessa X-20 (BD) in-
strument, and data analysis and color compensations were 
performed with FlowJo V9.5.3 software (Tree Star). Data are 
displayed on log and biexponential displays. For cell sorting, 
lymphocytes were incubated with the appropriate antibodies 
for detection of surface markers, and were then purified to 
>95% purity by high-speed sorting on an FAC 
SAria flow cytometer (BD).
In vitro culture. Thymocytes were cultured at 37°C with 5% 
CO2 in RPMI-1640 (Invitrogen) supplemented with 10% 
(vol/vol) FBS (Invitrogen), 0.1% (vol/vol) 2-mercaptoethanol 
βME (Sigma-Aldrich), and 1% (vol/vol) penicillin-strepto-
mycin (Invitrogen; RPMI-10). Recombinant TNF, BAFF, 
LIG HT, APR IL, TRA IL, GIT RL, CD70, and TLA1 were 
supplemented to cultures at 100 ng/ml unless otherwise state, 
and were obtained from R&D Systems, with PBS used as 
vehicle. IKK2 inhibitor Bl605906 was used at 10  µM in 
DMSO vehicle. Binding of RelA from nuclear extracts of 
TNF-stimulated thymocytes to NF-κB oligonucleotide was 
determined by specific ELI SA (Active Motif) according to 
the manufacturer’s instructions.
RNA sequencing. RNA was extracted from the cells using the 
Isolate II RNA mini kit (Bioline). RNA-seq libraries were 
prepared for sequencing using Illumina Truseq RNA Library 
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Preparation kit (Illumina) according to the manufacturer’s in-
structions. Samples were sequenced at the MRC National 
Institute for Medical Research High Throughput Sequencing 
Facility using an Illumina Genome Analyser IIx, and 36 bp 
single-end reads were obtained using the Illumina pipeline. 
Reads were aligned to the Mus musculus genome (mm9 as-
sembly) using CLC Genomic Workbench (V5) with standard 
settings. Aligned reads were mapped to the Ref Seq database 
and were normalized using the DESeq method (Anders and 
Huber, 2010) using Avadis NGS software V1.3.1. After nor-
malization, reads were displayed as reads per kilobase of exon 
per million reads (RPKM). Data are deposited in ArrayEx-
press, accession nos. E-MTAB-4778 and E-MTAB-4786.
Statistics. Statistical analysis and figure preparation were per-
formed using Graphpad Prism 6 (v6.0a). Column data com-
pared by nonparametric unpaired two tailed Mann-Witney 
Student’s t test while dose response curves were analyzed by 
two-way ANO VA. *, P < 0.05; **, P < 0.01; ***, P < 
0.001; ****, P < 0.0001.
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